Referencias bibliográficas

Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G, et al.; GLIA Consortium. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015 Apr;114(4):494-500. [Pubmed]
Waldman AT. Leukodystrophies. Continuum (Minneap Minn). 2018 Feb;24(1, Child Neurology):130-49. [Pubmed]
Resende LL, de Paiva ARB, Kok F, da Costa Leite C, Lucato LT. Adult Leukodystrophies: A Step-by-Step Diagnostic Approach. Radiographics. 2019 Jan-Feb;39(1):153-68. [Pubmed]
Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020 Feb;80(1):52-72. [Pubmed]
Vanderver A. Genetic Leukoencephalopathies in Adults. Continuum (Minneap Minn). 2016 Jun;22(3):916-42. [Pubmed]
Raymond GV, Moser AB FA. X-Linked Adrenoleukodystrophy. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2021. Disponible en: [Enalce]
Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, et al. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy. N Engl J Med. 2017 Oct 26;377(17):1630-8. [Pubmed]
Benzoni C, Moscatelli M, Fenu S, Venerando A, Salsano E. Metachromatic leukodystrophy with late adult-onset: diagnostic clues and differences from other genetic leukoencephalopathies with dementia. J Neurol. 2021 May;268(5):1972-6. Erratum in: J Neurol. 2021 Feb 23. [Pubmed]
Di Donato I, Banchi S, Federico A, Dotti MT. Adult-Onset Genetic Leukoencephalopathies. Focus on the More Recently Defined Forms. Curr Mol Med. 2014;14(8):944-58. [Pubmed]
Shukla A, Kaur P, Narayanan DL, do Rosario MC, Kadavigere R, Girisha KM. Genetic disorders with central nervous system white matter abnormalities: An update. Clin Genet. 2021 Jan;99(1):119-32. [Pubmed]
González-Pinto González T, Almeida Velasco J, Moreno Estébanez A, Agirre Beitia G, Cabral Martínez L, Díaz Cuervo I, Martínez Arroyo A. Acute management of a stroke-like episode in MELAS syndrome: What should we know? eNeurologicalSci. 2020 Jun 18;20:100249. [Pubmed]
Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, et al. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol. 2020 Jun;27(6):909-27. [Pubmed]
Hedderich DM, Lummel N, Deschauer M, Kümpfel T, Schuh E, Patzig M, et al. Magnetic Resonance Imaging Characteristics of Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations. Clin Neuroradiol. 2020 Jun;30(2):229-36. [Pubmed]
Chakrabarty S, Govindaraj P, Sankaran BP, Nagappa M, Kabekkodu SP, Jayaram P, et al. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. J Neurol. 2021 Jun;268(6):2192-207. [Pubmed]
Yu Z, Cao S, Wu A, Yue H, Zhang C, Wang J, et al. Genetically Confirmed CARASIL: Case Report with Novel HTRA1 Mutation and Literature Review. World Neurosurg. 2020 Nov;143:121-8. [Pubmed]
Finsterer J, Zarrouk-Mahjoub S. Stroke in MELAS is a Vasogenic Edema and not Ischemic. Basic Clin Neurosci. 2020 May-Jun;11(3):379-80. [Pubmed]
Rodan LH, Poublanc J, Fisher JA, Sobczyk O, Mikulis DJ, Tein I. L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome. PLoS One. 2020 Sep 3;15(9):e0238224. [Pubmed]
Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve. 2010 Nov;42(5):739-48. [Pubmed]
Hirano M, Emmanuele V, Quinzii CM. Emerging therapies for mitochondrial diseases. Essays Biochem. 2018 Jul 20;62(3):467-81. [Pubmed]